Close

FDA's Letter to Heron Therapeutics (HRTX) Over Sustol Approval

August 10, 2016 12:50 PM EDT

Below is the FDA's approval letter Heron Therapeutics' (Nasdaq: HRTX) SUSTOL:



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

FDA, Insiders' Blog